Maplelane Capital’s ASML ASML Stock Holding History

Maplelane Capital’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,000	Closed	-$23.9M	–	89
2026 Q1	$19.8M	Sell	15,000 -12,500	-45%	-$17.1M	0.71%	41
2025 Q4	$29.4M	Buy	+27,500	New	+$28.7M	1.04%	30
2025 Q3	–	Sell	-28,611	Closed	-$22.9M	–	94
2025 Q2	$22.9M	Sell	28,611 -53,389	-65%	-$38.3M	0.64%	46
2025 Q1	$54.3M	Buy	+82,000	New	+$59.7M	2.24%	13
2024 Q3	–	Sell	-92,500	Closed	-$95.5M	–	75
2024 Q2	$95.5M	Buy	92,500 +85,500	+1,221%	+$82.2M	3.27%	6
2024 Q1	$6.74M	Buy	+7,000	New	+$6.21M	0.22%	67
2021 Q3	–	Sell	-36,000	Closed	-$24.9M	–	95
2021 Q2	$24.9M	Buy	+36,000	New	+$23.7M	0.81%	37
2018 Q1	–	Sell	-1	Closed	–	–	135
2017 Q4	$0	Hold	1	–	–	﹤0.01%	117
2017 Q3	$0	Buy	+1	New	+$153	﹤0.01%	137
2015 Q2	–	Sell	-1	Closed	–	–	126
2015 Q1	$0	Buy	+1	New	+$105	﹤0.01%	147
2014 Q3	–	Sell	-1	Closed	-$94	–	138
2014 Q2	$0	Buy	+1	New	+$86	﹤0.01%	115

Other funds holding ASML

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Maplelane Capital's ASML Position: Q2 2026 in Review

Maplelane Capital sold out of ASML (ASML) in Q2 2026, closing a stake of 15,000 shares — an estimated $23.9M sold.

Maplelane Capital first reported a position in ASML in Q2 2014 and held it in 11 quarters. The position peaked at $95.5M in Q2 2024. 2,504 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

Maplelane Capital reported no remaining ASML position as of Q2 2026 after selling out during the quarter.
Maplelane Capital sold 15,000 ASML shares in Q2 2026, an estimated $23.9M.
Maplelane Capital first reported a position in ASML in Q2 2014 and held it in 11 quarters.
Maplelane Capital's ASML position peaked at $95.5M in Q2 2024.
2,504 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Maplelane Capital's 13F filing for Q2 2026, filed 13 Aug 2026.